Cipher Pharmaceuticals Inc.
TSX: CPH.TO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Toronto Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Craig J. Mull
- Employees
- 5
- Headquarters
- Mississauga, Canada
- IPO year
- 2004
- Market cap
- CA$499.1M
- Website
- https://www.cipherpharma.com
Loading CPH…
Loading profile data…Frequently asked questions about CPH
What does Cipher Pharmaceuticals Inc. (CPH.TO) do?
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treat...
Where does CPH.TO trade?
Cipher Pharmaceuticals Inc. (CPH.TO) trades on the Toronto Stock Exchange.
What sector is CPH.TO in?
Cipher Pharmaceuticals Inc. (CPH.TO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Cipher Pharmaceuticals Inc.?
Craig J. Mull is the chief executive officer of Cipher Pharmaceuticals Inc. (CPH.TO).
Where is Cipher Pharmaceuticals Inc. headquartered?
Cipher Pharmaceuticals Inc. is headquartered in Canada.
Does CPH.TO pay a dividend?
Cipher Pharmaceuticals Inc. (CPH.TO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CPH.TO go public?
Cipher Pharmaceuticals Inc. (CPH.TO) completed its initial public offering in 2004.